12.
Segments
General Information
The Company has a
single
operating segment, which was determined based on the chief operating decision maker (“CODM”), which is our Chief Executive Officer, assessing performance and allocating resources on a consolidated basis.
The operating segment derives its revenues primarily through sales of pharmaceutical and medical products. All long-lived assets were held in the United States as of December 31, 2024 and 2025. All revenues were generated in the United States during the years ended December 31, 2024 and 2025.
Measure of segment profit or loss and assets
The CODM assesses performance of the operating segment and decides how to allocate resources based on net income (loss), which also is reported on the consolidated statements of operations as net income (loss). In addition to comparing net income (loss) against forecasted net income (loss), the CODM uses net income (loss) to evaluate income generated from segment assets (return on assets) in deciding whether to reinvest profits into the operating segment or expansion of the operating segment through acquisitions.
 
 
The measure of operating segment assets is reported on the Consolidated Balance Sheets as total assets.
The accounting policies of the operating segment are the same as those described in the summary of significant accounting policies in Note 2.
Reportable segment reconciliation
The following reconciliation presents operating segment revenue, net income (loss), and significant segment expenses:
 
    
Operating Segment
 
    
2024
    
2025
 
Revenue
   $ 1,228,409      $ 1,448,685  
Less:
     
Employee expenses (excluding share-based compensation expense)
     268,621        309,600  
Share-based compensation expense
     131,490        13,850  
Other segment items
(1)
     871,725        1,028,812  
Depreciation and amortization
     19,772        22,335  
Interest expense
     3,278        665  
Income taxes
     4,556        24,465  
  
 
 
    
 
 
 
Segment net income (loss)
   $ (71,033    $ 48,958  
  
 
 
    
 
 
 
Reconciliation of net income (loss) to consolidated statements of operations
     
Adjustments and reconciling items
     —         —   
  
 
 
    
 
 
 
Consolidated net income (loss)
   $ (71,033    $ 48,958  
  
 
 
    
 
 
 
 
(1)
Other segment items included in operating segment net income include product expenses, legal expenses, rent and auto lease expenses, utilities expenses, maintenance expenses, and other overhead expenses.

Historical Timeline

Fiscal YearFiled
2025Mar 11, 2026Showing above
2024Mar 26, 2025

About Segments Disclosures

Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.

Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.